| Literature DB >> 3667305 |
R G Robinson1, J A Spicer, D F Preston, A V Wegst, N L Martin.
Abstract
We have utilized 89Sr as palliative treatment for bone pain secondary to metastatic cancer in the skeleton of over 200 patients. The best results have been in patients with carcinoma of the prostate (80% response rate) and breast (89%). Results in a small number of patients with a variety of other cell types were not nearly as encouraging. Strontium-89 provides excellent palliation in the management of bone pain secondary to prostate and breast carcinoma.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3667305 DOI： 10.1016/0883-2897(87)90045-6
Source DB: PubMed Journal: Int J Rad Appl Instrum B ISSN： 0883-2897